VEGFA and neoplasm: Furthermore, FGL2 knockdown hinders the activation of PAR2 and weakens downstream JNK phosphorylation, resulting in tumor cell cycle arrest, reduced expression of vascular endothelial growth factor (VEGF) and IL-8, and inhibition of tumor proliferation and angiogenesis [80].